id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-D-1137-0120,FDA,FDA-2020-D-1137,Development and Licensure of Vaccines To Prevent COVID–19; Guidance for Industry; Availability,Notice,Notice of Availability,2023-10-20T04:00:00Z,2023,10,2023-10-20T04:00:00Z,,2023-10-20T15:14:26Z,2023-23162,0,0,09000064861132e0
FDA-2020-D-1137-0121,FDA,FDA-2020-D-1137,Development and Licensure of Vaccines to Prevent COVID-19 Guidance for Industry,Other,Guidance,2023-10-20T04:00:00Z,2023,10,2023-10-20T04:00:00Z,,2025-08-29T09:00:27Z,,1,0,0900006486114f60
FDA-2020-D-1137-0119,FDA,FDA-2020-D-1137,Guidance Documents Related to Coronavirus Disease 2019 (COVID–19),Notice,General Notice,2023-03-13T04:00:00Z,2023,3,2023-03-13T04:00:00Z,,2023-03-13T14:30:04Z,2023-05094,0,0,090000648579c133